← Eichor
Study identifier: NCT05965180 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

Condition: Prostate Cancer  ·  Sponsor: University of Michigan Rogel Cancer Center

PhaseN/A
Planned participants50
Who can joinMale, 40 Years to 80 Years
Healthy volunteersNo

About this study

In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.

This description comes directly from the study's public registry record.

Talk to the study team

Cancer AnswerLine  ·  1-800-865-1125  ·  CancerAnswerLine@med.umich.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Michigan Rogel Cancer CenterAnn Arbor, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05965180